{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T22:02:53Z","timestamp":1767650573116},"reference-count":31,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2004,4,1]],"date-time":"2004-04-01T00:00:00Z","timestamp":1080777600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecular Brain Research"],"published-print":{"date-parts":[[2004,4]]},"DOI":"10.1016\/j.molbrainres.2004.01.006","type":"journal-article","created":{"date-parts":[[2004,3,17]],"date-time":"2004-03-17T11:29:34Z","timestamp":1079522974000},"page":"37-44","source":"Crossref","is-referenced-by-count":21,"title":["Doxycycline and protein folding agents rescue the abnormal phenotype of familial CJD H187R in a cell model"],"prefix":"10.1016","volume":"123","author":[{"given":"Yaping","family":"Gu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neena","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.molbrainres.2004.01.006_BIB1","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1212\/WNL.58.12.1720","article-title":"Drug therapy in human and experimental transmissible spongiform encephalopathy","volume":"58","author":"Brown","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.molbrainres.2004.01.006_BIB2","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1379\/1466-1268(1996)001<0117:CCCTMP>2.3.CO;2","article-title":"Chemical Chaperones correct the mutant phenotype of the delta F508 cystic fibrosis transmembrane conductance regulator protein","author":"Brown","year":"1996","journal-title":"Cell Stress Chaperones"},{"key":"10.1016\/j.molbrainres.2004.01.006_BIB3","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1212\/WNL.55.4.517","article-title":"Inherited prion encephalopathy associated with the novel PRNP H187R mutation: a clinical study","volume":"55","author":"Butefisch","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.molbrainres.2004.01.006_BIB4","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/S0002-9440(10)64572-5","article-title":"Effect of the E200 K Mutation on Prion Protein Metabolism: Comparative Study of a Cell Model and Human Brain","volume":"157","author":"Capellari","year":"2002","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.molbrainres.2004.01.006_BIB5","doi-asserted-by":"crossref","first-page":"6597","DOI":"10.1128\/JVI.65.12.6597-6603.1991","article-title":"N-terminal truncation of the scrapie-associated form of PrP by lysosomal protease(s): implications regarding the site of conversion of PrP to the protease-resistant state","volume":"65","author":"Caughey","year":"1991","journal-title":"J. Virol."},{"key":"10.1016\/j.molbrainres.2004.01.006_BIB6","doi-asserted-by":"crossref","first-page":"19173","DOI":"10.1074\/jbc.270.32.19173","article-title":"Truncated forms of the human prion protein in normal brain and in prion diseases","volume":"270","author":"Chen","year":"1995","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.molbrainres.2004.01.006_BIB7","doi-asserted-by":"crossref","first-page":"11604","DOI":"10.1074\/jbc.272.17.11604","article-title":"Identification of intermediate steps in the conversion of a mutant prion protein to a scrapie-like form in cultured cells","volume":"272","author":"Daude","year":"1997","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.molbrainres.2004.01.006_BIB8","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1038\/358761a0","article-title":"Processing of mutant cystic fibrosis transmembrane conductance regulator is temperature-sensitive","volume":"358","author":"Denning","year":"1992","journal-title":"Nature (Lond.)"},{"key":"10.1016\/j.molbrainres.2004.01.006_BIB9","doi-asserted-by":"crossref","first-page":"4894","DOI":"10.1128\/JVI.74.10.4894-4897.2000","article-title":"Lysosomotropic agents and cysteine Protease inhibitors inhibit scrapie-associated prion protein accumulation","volume":"74","author":"Doh-Ura","year":"2000","journal-title":"J. Virol."},{"key":"10.1016\/j.molbrainres.2004.01.006_BIB10","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1126\/science.286.5446.1882","article-title":"Setting the standards: quality control in the secretory pathway","volume":"286","author":"Ellgaard","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.molbrainres.2004.01.006_BIB11","doi-asserted-by":"crossref","first-page":"10849","DOI":"10.1073\/pnas.162195499","article-title":"Tetracyclines affect prion infectivity","volume":"99","author":"Forloni","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.molbrainres.2004.01.006_BIB12","doi-asserted-by":"crossref","first-page":"169","DOI":"10.3233\/JAD-2001-3202","article-title":"Isolation of human neuronal cells resistant to toxicity by the prion protein peptide 106\u2013126","volume":"3","author":"Gu","year":"2001","journal-title":"J. Alzheimer's Dis."},{"key":"10.1016\/j.molbrainres.2004.01.006_BIB13","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1074\/jbc.M104345200","article-title":"Prion peptide 106\u2013126 modulates the aggregation of cellular prion protein and induces the synthesis of potentially neurotoxic transmembrane PrP","volume":"277","author":"Gu","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.molbrainres.2004.01.006_BIB14","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1046\/j.1471-4159.2003.01255.x","article-title":"Intracellular aggregates of mutant prion protein upregulate the synthesis of potentially neurotoxic transmembrane PrP","volume":"84","author":"Gu","year":"2003","journal-title":"J. Neurochem."},{"key":"10.1016\/j.molbrainres.2004.01.006_BIB15","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1126\/science.279.5352.827","article-title":"A transmembrane form of the prion protein in neurodegenerative disease","volume":"279","author":"Hegde","year":"1998","journal-title":"Science"},{"key":"10.1016\/j.molbrainres.2004.01.006_BIB16","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1038\/45574","article-title":"Transmissible and genetic prion diseases share a common pathway of neurodegeneration","volume":"402","author":"Hegde","year":"1999","journal-title":"Nature"},{"key":"10.1016\/j.molbrainres.2004.01.006_BIB17","doi-asserted-by":"crossref","first-page":"42409","DOI":"10.1074\/jbc.M106928200","article-title":"Mutant prion proteins are partially retained in the endoplasmic reticulum","volume":"276","author":"Ivanova","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.molbrainres.2004.01.006_BIB18","doi-asserted-by":"crossref","first-page":"38699","DOI":"10.1074\/jbc.M005543200","article-title":"The chaperone protein BiP binds to a mutant prion protein and mediates its degradation by the proteasome","volume":"275","author":"Jin","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.molbrainres.2004.01.006_BIB19","series-title":"The pharmacological Basis of Therapeutics","first-page":"1123","article-title":"ANTIMICROBIAL AGENTS Tetracyclines, Chloramphenicol, Erythromycin, and Miscellaneous Antibacterial Agents","author":"Kapusnik-Uner","year":"1996"},{"key":"10.1016\/j.molbrainres.2004.01.006_BIB20","doi-asserted-by":"crossref","first-page":"9836","DOI":"10.1073\/pnas.161274798","article-title":"Acridine and phenothiazine derivatives as pharmacotherapeutics for prion disease","volume":"98","author":"Korth","year":"2001","journal-title":"Proc. Natl. Acad. Sci., U. S. A."},{"key":"10.1016\/j.molbrainres.2004.01.006_BIB21","doi-asserted-by":"crossref","first-page":"8508","DOI":"10.1074\/jbc.M110197200","article-title":"Cellular phenotyping of secretory and nuclear prion proteins associated with inherited prion diseases","volume":"277","author":"Lorenz","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.molbrainres.2004.01.006_BIB22","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/S0140-6736(01)05748-8","article-title":"Old drugs to treat new variant Creutzfeldt\u2013Jakob disease","volume":"358","author":"Love","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.molbrainres.2004.01.006_BIB23","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1038\/14053","article-title":"De novo generation of a PrPSc-like conformation in living cells","volume":"1","author":"Ma","year":"1999","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.molbrainres.2004.01.006_BIB24","doi-asserted-by":"crossref","first-page":"14955","DOI":"10.1073\/pnas.011578098","article-title":"Wild-type PrP and a mutant associated with prion disease are subject to retrograde transport and proteasome degradation","volume":"98","author":"Ma","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.molbrainres.2004.01.006_BIB25","doi-asserted-by":"crossref","first-page":"24554","DOI":"10.1074\/jbc.M200213200","article-title":"Cell surface accumulation of a truncated transmembrane prion protein in GSS P102L","volume":"277","author":"Mishra","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.molbrainres.2004.01.006_BIB26","doi-asserted-by":"crossref","first-page":"28461","DOI":"10.1074\/jbc.272.45.28461","article-title":"Prion protein aggregation reverted by low temperature in transfected cells carrying a prion protein gene mutation","volume":"272","author":"Singh","year":"1997","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.molbrainres.2004.01.006_BIB27","doi-asserted-by":"crossref","unstructured":"F. Tagliavini, G. Forloni, L. Colombo, G. Rossi, L. Girola, B. Canciani, N. Angeretti, L. Giampaolo, E. Peressini, T. Awan, L.D. Gioia, E. Ragg, O. Bugiani, M. Salmona, Tetracycline affects abnormal properties of synthetic PrP peptides and PrPSc in vitro (2000).","DOI":"10.1006\/jmbi.2000.3840"},{"key":"10.1016\/j.molbrainres.2004.01.006_BIB28","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1083\/jcb.129.1.121","article-title":"Cholesterol depletion and modification of COOH-terminal targeting sequence of the prion protein inhibit formation of the scrapie isoform","volume":"129","author":"Taraboulos","year":"1995","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.molbrainres.2004.01.006_BIB29","doi-asserted-by":"crossref","first-page":"6363","DOI":"10.1002\/j.1460-2075.1996.tb01027.x","article-title":"Chemical chaperones interfere with the formation of scrapie prion protein","volume":"15","author":"Tatzelt","year":"1996","journal-title":"EMBO J."},{"key":"10.1016\/j.molbrainres.2004.01.006_BIB30","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1006\/nbdi.2002.0502","article-title":"Chemical chaperones reduce aggregate formation and cell death caused by the truncated Machado\u2013Joseph disease gene product with an expanded polyglutamine stretch","volume":"10","author":"Yoshida","year":"2002","journal-title":"Neurobiol. dis."},{"key":"10.1016\/j.molbrainres.2004.01.006_BIB31","doi-asserted-by":"crossref","first-page":"23396","DOI":"10.1074\/jbc.274.33.23396","article-title":"Proteasomal degradation and N-terminal protease resistance of the codon 145 mutant prion protein","volume":"274","author":"Zanusso","year":"1999","journal-title":"J. Biol. Chem."}],"container-title":["Molecular Brain Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169328X04000397?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169328X04000397?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,3,31]],"date-time":"2020-03-31T17:14:34Z","timestamp":1585674874000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0169328X04000397"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,4]]},"references-count":31,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2004,4]]}},"alternative-id":["S0169328X04000397"],"URL":"https:\/\/doi.org\/10.1016\/j.molbrainres.2004.01.006","relation":{},"ISSN":["0169-328X"],"issn-type":[{"value":"0169-328X","type":"print"}],"subject":[],"published":{"date-parts":[[2004,4]]}}}